Unknown

Dataset Information

Butyrylcholinesterase predicts cardiac mortality in young patients with acute coronary syndrome.


ABSTRACT:

Background

The incidence of acute coronary syndrome (ACS) in young people (≤65 years) is continuously rising. While prognostic factors in ACS are well-investigated less attention has been paid to their age-dependent prognostic value and their particular relevance in younger patients. The aim of our study was to assess the age-dependent prognostic impact of butyrylcholinesterase (BChE).

Methods

Retrospective cohort study including 624 patients with ACS. Patients were stratified by age into equal groups (n = 208) corresponding to "young patients" (45-64 years), "middle-aged patients" (65-84 years) and "old patients" (85-100 years). Cox regression hazard analysis was used to assess the influence of BChE on survival.

Results

After a mean follow-up time of 4.0 (interquarti

SUBMITTER: Sulzgruber P 

PROVIDER: S-EPMC4416767 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature